{"id":3035,"date":"2021-04-23T16:31:03","date_gmt":"2021-04-23T13:31:03","guid":{"rendered":"https:\/\/staging.iasispharma.com\/en\/?p=3035"},"modified":"2026-10-30T13:29:49","modified_gmt":"2026-10-30T11:29:49","slug":"new-product-launch-coved","status":"publish","type":"post","link":"https:\/\/iasispharma.com\/en\/all-articles\/new-product-launch-coved\/","title":{"rendered":"COVED\u00ae NEW PRODUCT LAUNCH"},"content":{"rendered":"<p><strong>IASIS PHARMA<\/strong> has successfully launched\u00a0<strong>COVED\u00ae <\/strong>to the Greek market.<\/p>\n<p><img decoding=\"async\" class=\"size-medium wp-image-3081\" src=\"https:\/\/iasispharma.com\/wp-content\/uploads\/2021\/04\/box_coved-400X280-300x210.jpg\" alt=\"KM55-20-100 BOX COVED_70_5600\" width=\"300\" height=\"210\" srcset=\"https:\/\/iasispharma.com\/wp-content\/uploads\/2021\/04\/box_coved-400X280-120x84.jpg 120w, https:\/\/iasispharma.com\/wp-content\/uploads\/2021\/04\/box_coved-400X280-200x140.jpg 200w, https:\/\/iasispharma.com\/wp-content\/uploads\/2021\/04\/box_coved-400X280-300x210.jpg 300w, https:\/\/iasispharma.com\/wp-content\/uploads\/2021\/04\/box_coved-400X280.jpg 400w\" sizes=\"(max-width: 300px) 100vw, 300px\" \/><\/p>\n<p><strong>COVED<\/strong>\u00ae (Bisphosphonates, combinations) is a fixed dose combination of two active ingredients:<br \/>\n<strong>Alendronic acid<\/strong> (as alendronate sodium trihydrate) (<strong>70mg<\/strong>) &amp; <strong>Cholecalciferol<\/strong> (Vitamin D<sub>3<\/sub>) (<strong>5.600 I.U<\/strong>).<\/p>\n<p><strong>COVED<\/strong>\u00ae 70 mg \/ 5,600 IU is indicated for the treatment of postmenopausal osteoporosis in women at risk of vitamin D insufficiency. <strong>COVED<\/strong>\u00ae reduces the risk of both vertebral and hip fractures.<\/p>\n<p><strong>COVED\u00ae<\/strong> is available in a 4 tablet-pack (BTx4). Recommended dose: one tablet once weekly.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>IASIS PHARMA has successfully launched\u00a0COVED\u00ae to the Greek market. COVED\u00ae (Bisphosphonates, combinations) is a fixed dose combination of two active ingredients: Alendronic acid (as alendronate sodium trihydrate) (70mg) &amp; Cholecalciferol (Vitamin D3) (5.600 I.U). COVED\u00ae 70 mg \/ 5,600 IU is indicated for the treatment of postmenopausal osteoporosis in women at risk of vitamin D  [&#8230;]<\/p>\n","protected":false},"author":5,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_jetpack_newsletter_access":"","_jetpack_dont_email_post_to_subs":true,"_jetpack_newsletter_tier_id":0,"_jetpack_memberships_contains_paywalled_content":false,"_jetpack_hide_featured_image":false,"_jetpack_featured_image_duplicate_dismissed":0,"_jetpack_feature_clip_id":0,"_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2},"jetpack_post_was_ever_published":false},"categories":[33,146],"tags":[],"class_list":["post-3035","post","type-post","status-publish","format-standard","hentry","category-all-articles","category-product-launches"],"jetpack_publicize_connections":[],"jetpack_sharing_enabled":true,"jetpack_shortlink":"https:\/\/wp.me\/p7HJeP-MX","jetpack_featured_media_url":"","_links":{"self":[{"href":"https:\/\/iasispharma.com\/en\/wp-json\/wp\/v2\/posts\/3035","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/iasispharma.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/iasispharma.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/iasispharma.com\/en\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/iasispharma.com\/en\/wp-json\/wp\/v2\/comments?post=3035"}],"version-history":[{"count":4,"href":"https:\/\/iasispharma.com\/en\/wp-json\/wp\/v2\/posts\/3035\/revisions"}],"predecessor-version":[{"id":3084,"href":"https:\/\/iasispharma.com\/en\/wp-json\/wp\/v2\/posts\/3035\/revisions\/3084"}],"wp:attachment":[{"href":"https:\/\/iasispharma.com\/en\/wp-json\/wp\/v2\/media?parent=3035"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/iasispharma.com\/en\/wp-json\/wp\/v2\/categories?post=3035"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/iasispharma.com\/en\/wp-json\/wp\/v2\/tags?post=3035"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}